Makers of insulin pumps, glucose monitors modernize design
MINNEAPOLIS New gadgets are hitting or about to hit the market that will take glucose monitoring into this century, according to businessweek.com.
One of these items is a, Paradigm Real-Time System, a glucose monitor made by Medtronic. The device attaches to a patients’ belt, which is connected to a needle that is lodged in the skin of the abdomen. The monitor measures the levels up to 288 times per day.
Another diabetes testing unit is called the GlucoPhone; the Food and Drug Administration recently approved it. The glucose meter attaches to some LG electronics and Motorola phones. The phone displays the results after the patient inserts a strip into it.
The move for these new innovative products came as a way to satisfy customers and increase proper diabetic testing. A recent study by Italian researchers showed that patients using the PRT System experienced 70 percent less therapy-related dissatisfaction than those who repeatedly inject themselves.
Judge dismisses important J&J claim in Red Cross case
WASHINGTON A federal judge on Monday dismissed an important part of the lawsuit brought by Johnson & Johnson against the American Red Cross seeking to restrict the Red Cross’s use of its emblem on first aid, health, safety and emergency preparedness products, the Red Cross announced Tuesday.
The judge’s ruling dismissed entirely the J&J claim that the Red Cross promised not to engage in the sale of first aid, health, safety and emergency preparedness products.
“I appreciate the court’s decision and hope that Johnson & Johnson will reassess their actions and drop the case altogether,” stated Mark Everson, president and chief executive officer of the American Red Cross. “As the recent wildfires in California demonstrated, the Red Cross has an important mission to perform, and we want to put this distraction behind us and do the work the American people expect us to do.”
Following a hearing on Monday, Oct. 29, at the United States District Court for the Southern District of New York, Judge Jed Rakoff ruled that the “promissory estoppel” claim, a very significant portion of the pharmaceutical company’s lawsuit against the Red Cross, was “dismissed with prejudice.” The judge’s ruling also means that J&J cannot refile arguments on this claim.
The judge’s order comes nearly three months after J&J filed suit against the Red Cross for the Red Cross’ use of its emblem on products it sells to the public.
The court has set a schedule for hearing the remaining claims early next year.
Lil’ Drug Store signs exclusivity deal with Carmex
CEDAR RAPIDS, Iowa Lil’ Drug Store has been chosen to be the exclusive distributor of Carmex Lip Balm to the convenience class of trade, the company announced Wednesday.
“With over 140,000 convenience stores nationwide, this is a major opportunity for both Lil’ Drug and Carma,” stated Mike Pietsch, vice president of sales and marketing for Carma Laboratories, which distributes Carmex.